D. Layton

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D. Mark Layton, Dm Layton, D M Layton, D. M. Layton, D Mark Layton
Publication record
20 papers · 265 citations · H-index 7

PAPERS

Early‐onset reduced bone mineral density in patients with pyruvate kinase deficiency
20234 citationsauthor #8
Putting unstable hemoglobins on the map of London
20230 citationsauthor #3
P1522: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
20223 citationsauthor #2
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study.
202241 citationsauthor #2
Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
202213 citationsauthor #13
Mitapivat Improves Markers of Erythropoietic Activity in Long-Term Study of Adults with Alpha- or Beta-Non-Transfusion-Dependent Thalassemia
20225 citationsauthor #2
Voxelotor in sickle cell disease
20222 citationsauthor #4
RESULTS FROM A PHASE 2 STUDY OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
20211 citationsauthor #2
ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
20218 citationsauthor #2
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients
202052 citationsauthor #32
Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort
20203 citationsauthor #318
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.
201999 citationsauthor #5
A puzzling case of methemoglobinemia
20172 citationsauthor #4
Hypoxaemia, sport and polycythaemia: a case from Imperial College London
201510 citationsauthor #3
CHAPTER 8 – Erythroenzyme disorders
20110 citationsauthor #1
Pregnancy outcomes in sickle cell disease: a retrospective cohort study from two tertiary centres in the UK
201012 citationsauthor #6
Prospective screening of patients with sickle cell disease for the presence of pulmonary arterial hypertension as determined by tricuspid regurgitant jet velocity at echocardiography
20060 citationsauthor #7
Opiates for sickle-cell crisis? (multiple letters) [8]
19982 citationsauthor #1
Opiates for sickle-cell crisis?
19984 citationsauthor #1
Human parvovirus infection in sickle cell disease.
19934 citationsauthor #3

TIMELINE

1993 4 citations

1998 6 citations

2006 0 citations

2010 12 citations

2011 0 citations

2015 10 citations

2017 2 citations

2019 99 citations

2020 55 citations

2021 9 citations

2022 64 citations

2023 4 citations

D. Layton

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT